Benefit of buspirone on chemoreflex and central apnoeas in heart failure: a randomized controlled crossover trial

ConclusionsBuspirone reduces CO2 chemosensitivity and improves CA and oxygen saturation across the 24 h in patients with HF.

https://www.onlinelibrary.wiley.com/doi/abs/10.1002/ejhf.1854?af=R

Source: European Journal of Heart Failure - May 21, 2020 Category: Cardiology Authors: Alberto Giannoni, Chiara Borrelli, Gianluca Mirizzi, George B. Richerson, Michele Emdin, Claudio Passino Tags: Research Article Source Type: research